Back
Vornado Realty Trust 10K Form
Buy
60
VNO
Vornado Realty Trust
Last Price:
42.42
Seasonality Move:
6.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-06 | 10Q | VNO/Vornado Realty Trust Quarterly |
2024-02-12 | 10K | VNO/Vornado Realty Trust Annual |
2023-10-30 | 10Q | VNO/Vornado Realty Trust Quarterly |
2023-07-31 | 10Q | VNO/Vornado Realty Trust Quarterly |
2023-05-01 | 10Q | VNO/Vornado Realty Trust Quarterly |
2023-02-13 | 10K | VNO/Vornado Realty Trust Annual |
Receive VNO News And Ratings
See the #1 stock for the next 7 days that we like better than VNO
VNO Financial Statistics
Sales & Book Value
Annual Sales: | $1.81B |
---|---|
Cash Flow: | $105.38M |
Price / Cash Flow: | 14.96 |
Annual Sales: | $21.48 |
Price / Book: | 1.97 |
Profitability
EPS (TTM): | -0.29000 |
---|---|
Net Income (TTM): | $8.17M |
Gross Margin: | $906.01M |
Return on Equity: | 0.13% |
Return on Assets: | 0.05% |
Vornado Realty Trust Earnings Forecast
Key Vornado Realty Trust Financial Ratios
- The Gross Profit Margin over the past 24 years for VNO is 50.02%.
- The Selling, General & Administrative Expenses for VNO have been equal to 8.99% of Gross Profit Margin.
- The Interest Expense is 308.95% of Operating Income.
- The Net Earning history of VNO is 5.82% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 21 years.
Vornado Realty Trust Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Office REITs |
Sector: | Real Estate |
Current Symbol: | VNO |
CUSIP: | 929042 |
Website: | vno.com |
Debt
Debt-to-Equity Ratio: | 1.56 |
---|---|
Current Ratio: | 1.86 |
Quick Ratio: | 1.61 |
Price-to-Earnings
Trailing P/E Ratio: | 184.43 |
---|---|
Forward P/E Ratio: | 0 |
VNO Technical Analysis vs Fundamental Analysis
Buy
60
Vornado Realty Trust (VNO)
is a Buy
Is Vornado Realty Trust a Buy or a Sell?
-
Vornado Realty Trust stock is rated a Buy
The current Vornado Realty Trust [VNO] share price is $42.42. The Score for VNO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.